The carcinogens to which humans are exposed are normally in the form of complex mixtures, and much effort has gone into determining the nature of the most significant carcinogenic components in these mixtures and their mechanisms of action. Essential to achieving this aim in exposed populations is the use of biomarkers, which can 
efficiently) seem important areas for the future assessment of the effects of human exposure to environmental genotoxins, together with studies of dose-response relationships at low doses.
INTRODUCTION
Biomarkers are playing an increasing role in the assessment of human exposure to hazardous environmental pollutants and in risk assessment to these compounds [1, 2] .
As indicated in figure 1, biomarkers may be applied at any stage in the toxicological process, ranging from measurement of the external dose as an indicator of exposure to determining altered structure and function of cells as a biomarker of effect ( Figure 1 ).
All of these biomarkers have value in specific circumstances. Thus for example biomarkers towards the right of the scheme advise more on health effects, whereas those towards the left of the scheme inform us more on the nature of the environmental agent and its source and concentration.
In the ideal situation one would like to know of the linkages between biomarkers of exposure to biomarkers of effect and susceptibility and to adverse health effects, in order that one could derive risk assessment from the former. Although some examples exist where such relationships are known, e.g. blood levels of lead [3] , and blood and hair levels of mercury [4] , used as biomarkers for neurodevelopmental effects, this is generally not the case. More commonly, highly sensitive assays of exposure have been developed but the health effects associated with these is unknown, i.e. the nature of the dose-response relationship at low doses is unknown.
Endogenous formation of some biomarkers may additionally complicate the assessment of the external exposure, an example being ethylene oxide which is produced endogenously from metabolism of ethylene, possible sources of ethylene/ethylene oxide being methionine oxidation, lipid peroxidation, and the metabolising activity of intestinal bacteria [5] . Finally as environmental pollutants are normally present in complex mixtures there is also the possibility of synergistic or antagonistic interactions which may affect the toxicity associated with a particular component.
In this review we will primarily focus on the determination of DNA adducts by mass spectrometry that indicates the biologically effective dose of environmental genotoxic carcinogens in humans. We will try to illustrate the progress in this field when compared to analysis of DNA adducts by other techniques and also highlight the limitations associated with the interpretation of DNA adduct determinations for genotoxic exposure and how these are being overcome.
BIOMARKERS OF BIOLOGICALLY EFFECTIVE DOSE OF GENOTOXIC CARCINOGENS: DNA ADDUCT DETERMINATION
Genotoxic carcinogens interact with nucleic acids to produce adducts, measurement of which is an indicator of the dose of active material which has reached the cells under study, termed the biologically active dose, in the individual being investigated. This thereby incorporates the effects of interindividual variation in absorption, metabolism and excretion of the compound which may affect risk assessment.
Methodology for human DNA adduct determination
The analytical methods for the determination of DNA adducts vary greatly in their sensitivity, selectivity, and practicality (e.g sample workup conditions, cost etc) for human studies [6, 7] . All have their own advantages and disadvantages. Some of the most commonly used assays (e.g. TLC, from cigarette smoke-associated lung DNA [13] .
The sensitivity of 32 P-postlabelling is limited by the specific activity of the isotope used, and by the yield of the labelling process, which should be determined if accurate quantitation is required.
Fluorescence-based techniques
The fluorescence characteristics of certain adducts allow their sensitive detection and quantitation. HPLC coupled to fluorescent detection has been widely used, for example for determination of DNA adducts of PAHs [14, 15] and of aflatoxin B 1 [16] .
Sensitivities are as high as ca 1 adduct/10 8 nucleotides, although the use of this approach is limited as not all compounds hold suitable fluorescent properties. Extra selectivity may be achieved using synchronous fluorescence spectrophotometry (SFS) in which excitation and emission wavelengths are monitored synchronously [17, 18] .
Of particular interest at present is the development of assays that combine capillary electrophoresis (CE) for separation of the adduct with laser induced fluorescence 
Electrochemical detection
Electrochemical detection has been shown to be of sufficient sensitivity for adduct detection, in conjunction with HPLC separation, although its use is somewhat limited as not all compounds hold suitable electrochemical properties. Oxidative damage of DNA (notably 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG)) has been particularly well studied by this technique [29, 30] although great care needs to be taken to avoid artifactual formation of such oxidised products [31] .
Comet assay (Single cell gel electrophoresis)
Single cell gel electrophoresis, or the Comet assay, is being increasingly used for the detection of single and double strand breaks resulting from genotoxin damage [32, 33] . Although the nature of the chemical that caused these cannot be identified from this approach, methods have been developed for making the procedure more specfic for certain lesions, e.g the use of formamidopyrimidine DNA glycosylase (Fpg) for detection of 8-oxodG. Unlike the other approaches described the Comet assay requires cells rather than isolated DNA for the analysis, which has to be taken into consideration in the design of molecular epidemiology studies.
Use of mass spectrometry (MS) in DNA adduct detection
The use of MS for the detection of DNA adducts has been the subject of several comprehensive reviews e.g. Singh and Farmer [34] , with particular reference to electrospray ionisation (ESI)-liquid chromatography (LC)-MS, Esmans et al. [35] Andrews et al. [36] , Doerge et al. [37] , Koc and Swenberg [38] and Watson et al. [39] . The approaches most usually employ collision induced dissociation (CID) tandem MS (MS/MS) with selected reaction monitoring (SRM) for the determination of:
• adducted 2'-deoxynucleosides separated from enzymically digested DNA tamoxifen adducts in a study of hepatocarcinogenesis in rats [42] ; pyridyloxobutyl adducts in rat tissue DNA derived from the tobacco specific nitrosamines NNN and NNK [43] ; heptanone-etheno adducts in mouse tissue [44] ; the oxidative lesions of guanine, oxazolone and 8-oxodG in rat liver [45] ; 8-oxodG in chemopreventive trials in mice [46] .
Adducted purine bases derived from thermal depurination of DNAexperimental studies
Recent studies on adducted purine bases derived from thermal depurination of DNA include our development of a sensitive assay for the determination of N-7 (2-hydroxyethyl)guanine. This approach (illustrated in Figure 3A ) has a limit of detection of 0.1fmol on column equivalent to 6 adducts/10 9 nucleotides, sufficient to detect background (endogenously formed) levels of adducts in rats, 1.1-3.5
adducts/10 8 nucleotides [47] . Thermal depurination of DNA was also recently reported to have been used by Lao et al [43] to study pyridyloxobutyl adducted guanine, as a possible marker of tobacco specific nitrosamine exposure.
Human studies: determination of adducts in tissue DNA and of urinary modified bases or 2'deoxynucleosides derived from DNA repair or the nucleotide pool
We have recently completed a major study on the determination of 8-oxodG by LC-MS/MS in human lymphocyte DNA [28, 48] . The aim of this was to evaluate the relationship between exposure to environmental air pollution and endogenous oxidative DNA damage in human populations with varying exposure from three cities (Prague (Czech Republic), Kosice (Slovak Republic) and Sofia (Bulgaria)).
Populations exposed to urban pollution and controls were studied. The level of 8-oxodG was significantly increased in individuals in Kosice exposed to environmental air pollution compared to unexposed individuals. Of interest was the negative correlation between the level of 8-oxodG adducts and the level of total PAH (bulky) and B[a]P DNA adducts [48] . More recently we have studied the excretion of 8-oxodG in human urine [49] , using an adaptation of the procedure we derived for 8-oxodG analysis in DNA. For urinary analysis the sample was analysed after purification with solid-phase extraction with a recovery of 81% and limit of detection of 5 fmol on column [49] . Levels of 0.41 + 0.39 pmol/μmol creatinine were found in urine of human volunteers ( Figure 3B ).
Other recent examples of using MS for the determination of urinary modified bases and deoxynucleosides are: N-7 ethylguanine in urine from smokers and non-smokers [50] ; etheno-DNA adducts in human urine after olive oil ingestion [51] , aflatoxin B 1 -guanine in human urine as a marker of intake of dietary aflatoxin B 1 [52] ; Oltipraz is being examined as a possible chemopreventive agent for aflatoxin and its effect on DNA oxidation was studied by analysis of oxidized guanine derivatives in human urine by LC-MS/MS [53] .
Other DNA adducts recently detected in human tissues include 1,N 2 -propanodeoxyguanosine adducts derived from acetaldehyde and crotonaldehyde in lung and liver tissues [54] and acetaldehyde-derived adducts (as a possible marker of ethanol genotoxicity) in human liver, measured after reduction as N 2 ethyl-2′-deoxyguanosine [55] , 4-ABP adducts in DNA from human bladder [56] ; endogenous cyclic DNA adducts derived from trans-4-hydroxy-2-nonenal with 2′-deoxyguanosine in human brain tissues [57] and N-7 ethylguanine in human liver [58] .
Accelerator mass spectrometry (AMS)
For a limited number of LC-MS assays the sensitivity matches that of 32 Ppostlabelling (the DNA adduct measuring technique which is most widely applicable and most commonly used), although this is not the case for many adducts. When greater sensitivity is required using mass spectral techniques, one possibility is to use AMS, which measures isotope ratios. This is the most sensitive analytical method so far available for detecting DNA adducts, with a limit of detection that may be as low as 1 adduct per 10 12 nucleotides [59] . AMS has been used to detect the isotopic content of adducts after administration of labelled ( 
Long lifetime DNA adducts
The lifetime of DNA adducts is very variable, dependent on their repair mechanism and their chemical stability, which must clearly be taken into consideration in designing biomarker studies. One measurement which would be of benefit to epidemiologists would be that of an adduct which was not repaired and which would give a long term assessment of genotoxin exposure. One possibility may be to determine phosphotriesters (PTEs) [68] . In addition to reacting with DNA bases, many genotoxic agents react with the oxygen of the internucleotide phosphodiester linkages to form PTEs. These compounds include N-alkylnitrosoureas, dialkylsulfates, alkyl methanesulfonates, cyclophosphamide and cyanoethylene oxide. [73] . Further development of such approaches to make them applicable for human monitoring seems desirable.
Assessment of mass spectral approaches for the detection of DNA adducts, recent advances and future prospects
The advantages of the use of MS for determination of DNA adducts are that it gives improved structural characterisation compared to other methods, and allows extremely accurate quantification. Also unlike most of the methods discussed above, the sensitivity and selectivity of mass spectrometric approaches continues to rise, as Figure 4E shows the DNA adducts from B[a]P and DB[a,l]P being monitored simultaneously following the dosing of HepG2 cells with an equimolar mixture of both PAHs, and many more adducts could be added to such an analysis.
The concept of producing a screen of all DNA adducts in a sample by monitoring a large range of such MH + to [MH-116] + transitions was proposed by Kanaly et al. [78] and preliminary work on inter-tissue variation of adducts has been reported [79] . This technique holds great potential for gaining further structural information on adduct differences between populations exposed to environmental genotoxins and corresponding controls.
There are also exciting new possibilities for future improvements in interfacing sample separation to the mass spectrometer, with high sensitivity and minimal sample sizes, using LC chips. These use microfluidics-based technology for high-pressure nanoflow LC-MS systems, and incorporate the sample purification, separation and electrospray interface on a single chip thus allowing the processing of lower volume samples with complete automation of the analysis procedure and the possibility of screening based applications [80, 81, 82] .
Validation of DNA adduct determination and its use in risk assessment
In order for DNA adduct measurements to be used in risk assessment procedures, validation is necessary both for the analytical procedures and for the ability of adducts to predict disease in molecular epidemiological studies. [26, 89, 90] . In all of these studies there were inter-laboratory comparison of DNA samples that were modified in vitro, extracted from exposed animals and, in the case of B[a]P extracted from human tissue. However further work still needs to be carried out using interlaboratory trials for MS determination of DNA adducts.
With regard to the validation of the use of DNA adduct formation as a biological predictor of cancer, it is generally believed that the extent of DNA adduct formation is indicative of biological risk. The classic demonstration of a relationship of adducts with disease is the pioneering study by Ross et al. [91] which showed that the excretion of a urinary aflatoxin B 1 -guanine adduct was statistically related to the subsequent incidence of hepatocellular carcinoma in a nested case control study of a
Chinese population who were ingesting aflatoxin B 1 in their diet [92] . A recent study by Gunter et al. have found that there was a 2.8-fold increase in the risk of colon adenoma in the quartile of individuals with the highest white blood cell PAH DNA adduct levels compared to the lowest quartile [93] . Many other associations have been drawn between adducts and biological effect in human studies, which have been well summarised in the review of Kyrtopoulos [94] . Overall there is mounting evidence that suggests that DNA adducts (the evidence being notably for bulky adducts) are associated with higher cancer risk on a population basis. However it should be noted that the nature of the dose-response relationship is uncertain at low doses and that there is evidence for saturation of some adduct levels (i.e. a non-linear dose response)
at high exposure [95, 96] . Also to improve the interpretation of the results we need more information on intra-individual variation, and genetic factors affecting an individual's susceptibility.
CONCLUSION
Mass spectrometry has made enormous gains in its applicability for the detection of DNA adducts, and it is now possible to determine DNA adducts by MS with a sensitivity comparable to that of the other analytical approaches available for adduct detection, such as 32 P-postlabeling or immunoassays. Highly accurate and reproducible data can be obtained indicating that MS should provide more reliable results for biomonitoring of exposure to genotoxic carcinogens in human molecular epidemiological studies. Despite the potential availability of such data, one of the major questions remaining in the field of risk assessment to environmental carcinogens is whether or not there is a threshold in the dose response relationship.
For human biomonitoring of such environmental chemicals, the current situation is that the analytical methods for biomarkers of exposure have developed faster than our ability to understand the relationship between these biomarkers and biological outcome, i.e. we are not able to estimate risk directly from exposure biomarkers for many compounds. This is particularly the case for biomarkers of genotoxic carcinogens, where the DNA damage produced by genotoxic carcinogens (adducts)
can often be detected at very low levels in human tissues, but biological effects are unknown, and may indeed be unmeasurable using existing assays. The result of this is that there is a paucity of data regarding the nature of the dose-response relationship at low doses, and also whether or not thresholds exist below which there is no tangible risk to humans.
Many highly sensitive mass spectrometric methods now exist for the determination of DNA adducts, and the main current requirement is to validate these both analytically and in molecular epidemiology studies. In view of the likely need to store samples over extended periods a greater understanding of stability of adducts is also required.
Development of sensitive mass spectrometric DNA adduct screening systems, and of long-term biomarkers (e.g. adducts that are not repaired) seem important areas for the future assessment of the effects of human exposure to environmental genotoxins, together with studies of dose-response relationships at low doses.
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